PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsNovo Nordisk
Novo Nordisk(NVO)
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries, and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a supermajority (45%) of its voting shares.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ActraphaneInsulin human (rdna)2002-10-07
ActrapidHuman insulin (rdna)2002-10-07
EsperoctAntihemophilic factor (recombinant), glycopegylated, Turoctocog alfa pegol2019-02-19
FiaspInsulin aspart2017-09-29
GlucagenGlucagon1998-06-222036-2039
InnofemEstradiol1999-11-192024-2037
InsulatardInsulin human (rdna)2002-10-07
LevemirInsulin detemir2005-06-16
MacrilenMacimorelin2017-12-202027
MixtardInsulin human (rdna)2002-10-07
MonotardInsulin human (rdna)2002-10-07
NorditropinSomatropin2000-06-20
1
2
3
4
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Somapacitan
Glucagon
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use